RxDoctor Payments Data

Carolyn Estepp, APRN

Family · Ashland, KYNPI 1184872608

Payments from drug & device makers

$387in general payments, 2019–2025

Across 24 payments — averaging $16.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$129
  • Biohaven Pharmaceutical Holding Company Ltd.$70
  • Biohaven Pharmaceuticals, Inc.$54
  • AstraZeneca$39
  • Novo Nordisk$33
  • Johnson & Johnson$31
  • plus $32 from 2 others

What the payments were for

  • Food & beverage$37597%
  • Education$123%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$387 in reported general payments places this provider in the 45th percentile of 4,374 family providers in Kentucky.

See all family providers in Kentucky

Medicare billing

Part B allowed, 2024
$29,092
Medicare patients
99
Services billed
477

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide42$54,467
MounjaroTirzepatide39$41,692
JardianceEmpagliflozin23$32,350
JanuviaSitagliptin Phosphate15$23,330
Breztri AerosphereBudesonide/Glycopyr/Formoterol24$15,544
TrulicityDulaglutide12$12,949
Albuterol Sulfate HfaAlbuterol Sulfate101$2,658
Potassium Chloride87$2,156
Pregabalin18$1,882
Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate11$1,525
Levothyroxine Sodium191$1,420
Pantoprazole Sodium101$1,283
Atorvastatin Calcium141$1,127
Omeprazole142$1,071
Desvenlafaxine Succinate ErDesvenlafaxine Succinate13$1,068

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$33$54,46742 claims
AstraZenecaBreztri Aerosphere$39$15,54424 claims
AbbVieSynthroid$129$1,06719 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 45th percentile of 4,374 family providers in Kentucky.

Other family in Ashland

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →